NTT DATA Group Corporation (NTTDF)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 29, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	37,286	25,107	22,501	18,267	27,924	21,722
Market Cap Growth	11.58%	11.58%	23.18%	-34.59%	28.55%	60.25%
Enterprise Value	60,322	47,630	41,305	36,817	32,142	26,428
Last Close Price	28.00	15.93	15.37	13.45	19.28	15.77
PE Ratio	39.19	26.39	25.42	16.19	23.72	31.27
PS Ratio	1.20	0.81	0.78	0.70	1.33	1.04
PB Ratio	1.95	1.31	1.22	1.01	2.55	2.13
P/TBV Ratio	-	-	-	-	12.54	13.34
P/FCF Ratio	-	-	-	-	25.04	12.69
P/OCF Ratio	14.06	9.47	6.82	6.93	10.92	6.82
EV/Sales Ratio	1.94	1.54	1.43	1.40	1.53	1.26
EV/EBITDA Ratio	13.03	10.37	9.60	9.23	9.02	8.29
EV/EBIT Ratio	27.62	22.02	20.18	19.03	18.36	21.15
EV/FCF Ratio	-30.84	-	-	-	28.82	15.43
Debt / Equity Ratio	0.99	0.99	0.88	0.84	0.50	0.66
Debt / EBITDA Ratio	4.12	4.12	3.77	3.77	1.53	2.09
Debt / FCF Ratio	-	-	-	-	4.90	3.90
Asset Turnover	0.62	0.62	0.65	0.76	0.85	0.83
Inventory Turnover	62.56	62.56	49.78	50.53	94.02	122.97
Quick Ratio	0.70	0.70	0.73	0.93	0.93	0.96
Current Ratio	0.97	0.97	0.97	1.26	1.26	1.20
Return on Equity (ROE)	4.93%	4.93%	5.62%	8.96%	12.23%	7.73%
Return on Assets (ROA)	2.70%	2.70%	2.89%	3.48%	4.44%	3.09%
Return on Capital (ROIC)	3.70%	3.70%	4.02%	5.03%	6.89%	4.78%
Return on Capital Employed (ROCE)	6.50%	6.50%	6.60%	5.90%	10.10%	7.00%
Earnings Yield	2.55%	3.79%	3.93%	6.18%	4.22%	3.20%
FCF Yield	-5.25%	-7.79%	-4.57%	-0.67%	3.99%	7.88%
Dividend Yield	0.61%	1.05%	0.99%	1.23%	0.81%	1.03%
Payout Ratio	23.63%	23.63%	24.09%	15.25%	18.14%	32.85%
Buyback Yield / Dilution	-0.01%	-0.01%	0.01%	0.02%	0.01%	0.00%
Total Shareholder Return	0.60%	1.04%	1.00%	1.25%	0.82%	1.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.